The biotechnology industry has always appealed to investors looking for the next home run investment. One niche within that industry that appears poised to soar deals with small molecule drugs used to treat diseases. With billions of dollars being poured into this space each year, the stakes are high but so are the rewards. One company that appears on the verge of appreciating significantly is BioCryst Pharmaceuticals (NASDAQ:BCRX). Below are several reasons why investors should consider adding a position soon.
BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in infectious and inflammatory diseases. BioCryst uses revolutionary drug design, which incorporates multiple scientific disciplines including biology, crystallography, medicinal chemistry and computer...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|